论文部分内容阅读
目的探讨厄贝沙坦治疗高血压心脏病的临床效果。方法选择70例高血压心脏病患者,患者暂停治疗药物1个月后服用厄贝沙坦,记录患者在治疗期间的血压变化,并观察疗效和不良反应发生率。结果治疗后患者舒张压及收缩压均较治疗前降低,差异有统计学意义(P<0.05)。治疗有效率为92.86%,不良反应发生率为8.57%。结论厄贝沙坦治疗高血压心脏病临床疗效较好,不良反应少。
Objective To investigate the clinical effect of irbesartan on hypertensive heart disease. Methods Seventy patients with hypertensive heart disease were enrolled. Patients were given irbesartan one month after treatment was discontinued. The changes of blood pressure during the treatment were recorded. The curative effect and incidence of adverse reactions were observed. Results After treatment, the diastolic blood pressure and systolic blood pressure were lower than before treatment, the difference was statistically significant (P <0.05). The effective rate was 92.86% and the rate of adverse reactions was 8.57%. Conclusion Irbesartan treatment of hypertensive heart disease has good clinical efficacy and few adverse reactions.